Insulia receives FDA clearance and CE mark to integrate Basaglar and Tresiba. See the press release >

This press section is intended for journalists and investors for their professional use.

WHAT’S NEW
AT VOLUNTIS ?

ABOUT VOLUNTIS

Voluntis is dedicated to developing companion software that empowers patients to self-manage their chronic disease in collaboration with their medical team.

DOWNLOAD PRESS KIT

Working on a Voluntis story? We can help.



Press contact :
Amélie Janson
(617) 245-4125

  • Meet Insulia®

    What is companion software?

  • Tomorrowland: medical treatment in 2020

Meet Insulia®

What is companion software?

Tomorrowland: medical treatment in 2020

PRESS RELEASES

november 2017

Insulia receives FDA clearance and CE mark to integrate Basaglar and Tresiba

october 2017

Digital Therapeutics Alliance Established to Advance Novel Technologies Aimed at Transforming Patient Clinical Outcomes

july 2017

Insulia® receives FDA clearance and CE mark to integrate Toujeo®

june 2017

Voluntis and Ascensia Diabetes Care announce technology partnership to help optimize insulin management for people with Type 2 diabetes

april 2017

Voluntis adds Scott Honken to Leadership Team to strengthen payer & provider focus

march 2017

Voluntis and Sanofi announce a global alliance to deliver digital insulin titration solutions for people with type 2 diabetes

february 2017

Voluntis and Livongo Partner to Deliver Insulin Titration App

december 2016

Voluntis receives FDA clearance and CE mark for Insulia® a first for digital applications supporting type 2 diabetes patients treated with basal insulin

december 2015

Voluntis and AstraZeneca to test companion mobile app in ovarian cancer studies with the US National Cancer Institute

september 2015

Roche Pharma France and Voluntis partner to develop first therapeutic companion solution for women afflicted with breast cancer

june 2015

Voluntis announces election of Eric Elliott as Chairman of the Board of Directors

april 2014

Voluntis raises $29M in fundraising round

december 2013

Voluntis Insulin Therapy Manager receives CE Mark

october 2013

Diabeo highlighted at Objets de la Nouvelle France Industrielle by Mr Arnaud Montebourg, Minister of Industrial Renewal

september 2013

Voluntis wins the 2013 Up and Coming Company Award

july 2013

Voluntis appoints Nicolas Cartier to the Supervisory Board as an Independent Director

VOLUNTIS IN THE NEWS

october 2016 - Les Echos

Voluntis : un leader mondial de l'e-santé

july 2016 - iMedicalApps

eCO Study App created by pharma to specifically monitor two key side effects

june 2016 - The doctor weighs in

Creating Medical Apps That Actually Get Used

december 2015 - MobiHealthNews

AstraZeneca taps Voluntis for ovarian cancer treatment companion app